The electronic patch device produces the report mailed to the hospital from home after 72 hours. market surveys used by Opto circuit use a $500 mln market size as basis.  This mysense heart device was approved last week.

Wayward/Baseless revenue estimates based on optimistic foretelling by the industry as is the wont in the last 10 years of India's new product introduction in the west apart the company could definitely do with $ 20 mln in extra Dollar revenue with the currency run expected to continue.

Opto does not have any liabilities in Dollars and may convert this dollar revenue to good profits. Its other product business revenue streams were locked last year in Japan

The company is not getting good yields in some invasive device businesses where it needs more investor partners,and wants to list in the next six months with existing PE partners where it can As told to ETNow (inthe brief) the company wants to roll out further devicess for FDA approval in the next  2 years

Posted via email from The India Investment Post